Quality in Care nominations open
3rd March 2016
Submissions for this year’s prestigious Quality in Diabetes Care (QiC) awards have opened. The announcement was made during the Diabetes UK Professional Conference in Glasgow where several ...
Sanofi
Warning over Insuman supply shortage
10th December 2015
People who use Insuman pre-filled pens and cartridges have been warned of a temporary supply shortage of the products. Sanofi, the company which makes the items, said the limited availability ...
Toujeo insulin gets Scottish go ahead
9th September 2015
Sanofi’s Toujeo® (Insulin glargine 300 units/mL) has been approved for use in Scotland, the pharmaceutical company has announced. The Scottish Medicines Consortium (SMC) has approved the ...
Sanofi’s Insulin Toujeo® now available for treatment of adults with diabetes in UK
4th August 2015
Sanofi has announced today that Toujeo® (insulin glargine [rDNA origin] 300 units/mL), a long-acting, once-daily basal insulin treatment is available for clinicians to prescribe in the UK. The ...
Sanofi Announces First LixiLan Phase III Study Meets Primary Endpoint
29th July 2015
Sanofi’s combination type 2 diabetes drug LixiLan has met its primary endpoint in its first Phase III trial. The pharmaceutical firm announced today that the LixiLan-O Phase III clinical trial ...
Sanofi announces top-line results for cardiovascular outcomes study of Lyxumia® (lixisenatide)
19th March 2015
Sanofi has today announced top-line results of the Phase IIIb ELIXA cardiovascular outcomes study, which compared lixisenatide to placebo in a high-risk population of adults with Type 2 diabetes ...
Sanofi’s Toujeo® receives positive opinion from European regulatory authority
2nd March 2015
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has announced a positive opinion recommending variation to the marketing authorisation of Toujeo (insulin ...
Inhaled insulin available in US
13th February 2015
An inhaled insulin has gone on sale in America this month. Afrezza, developed by MannKind and licensed to pharmaceutical company Sanofi, is available in the US market for people with Type 1 or ...
Sanofi release children’s diabetes app
7th September 2014
A new app to encourage children to learn more about how to live with diabetes has been launched. Mission T1D by Sanofi Diabetes is aimed at children with Type 1 diabetes and their parents and ...
Type 1 children’s app shortlisted for top award
25th July 2014
A new healthcare app aimed at helping children with Type 1 diabetes better manage their condition has been shortlisted in the Health Service Journal (HSJ) Value in Healthcare Awards. Monster ...